In this study, the use of midodrine and octreotide significantly improved serum sodium concentration and urinary EFWC in our small group of patients with cirrhosis complicated by ascites (as evidence of portal hypertension) and whose hyponatremia failed to improve with albumin challenge for 48 h. The gene discussed is ALB; the disease is Hyponatremia.